Clinical Trial Update: The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring nebulized hydroxychloroquine for treating COVID-19 is in early stages with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 2019 Novel Coronavirus

Drugs mentioned

• hydroxychloroquine inhalation (nebulized) (hydroxychloroquine)

Snippet

Sponsor: Ministry of Health Jordan | Conditions: 2019 Novel Coronavirus | Phase 2 | Status: UNKNOWN